Sea Crest Wealth Management, LLC Biomarin Pharmaceutical Inc Transaction History

Sea Crest Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$80.35 - $93.9 $8,597 - $10,047	-107 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$84.2 - $98.62 $3,452 - $4,043	41 Added 62.12%	107 $10,000
Q4 2018 Feb 13, 2019	SELL	$80.14 - $106.07 $2,724 - $3,606	-34 Reduced 34.0%	66 $6,000
Q2 2018 Aug 03, 2018	BUY	$76.01 - $99.03 $6,916 - $9,011	91 Added 1011.11%	100 $9,000
Q4 2017 Feb 02, 2018	BUY	$80.76 - $95.13 $726 - $856	9	9 $1,000

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.